The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The US Food and Drug Administration (FDA) has decided that only seniors and people at high risk should get the latest COVID-19 booster shots this fall.

At the outset of the meeting, the FDA's new top vaccine regulator, Vinay Prasad, said he and FDA leaders wanted to "give people a little more time to digest the policy." He said that the FDA is still ...

Secretary Kennedy's appointment led to fears that vaccine availability would be curtailed. Those fears are now being realized.

If I am unable to access a vaccine in the future and get a nasty case of COVID, I'll know where to point the finger and so will millions of others.

The United States is tightening its approval standards for COVID-19 boosters, a shift that has prompted growing concern in ...

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...